140 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
before any adjourned meeting. For this purpose, the time of receipt will be taken to be the time (as determined by the time stamp applied to the message … of shareholders;
-21-
the appointment, compensation, retention and oversight of any accounting firm engaged for the purpose of preparing or issuing
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
interpreted the statute’s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal … ;
the appointment, compensation, retention and oversight of any accounting firm engaged for the purpose of preparing or issuing an audit report or performing other
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
in accordance with Nasdaq rules for the purpose of information, if it is contained in public records, if it is readily acquired by those likely to deal … .
The purpose behind the Closed Period is to help establish a diligent effort to avoid any improper transactions. All Covered Persons must comply
10-K
2023 FY
EX-4.2
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
of different kinds and the liquidator may for such purpose set such value as the liquidator deems fair upon any one or more class or classes of property … shares out of the distributable profits of the company or the proceeds of a fresh issue of shares made for the purpose of financing the purchase
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, dossiers and the like submitted to a Regulatory Authority for the purpose of obtaining Regulatory Approval;
“ReproNovo” has the meaning set forth … as at the Effective Date; Mereo gives no warranty or representation as to the suitability of such Tangible Materials for any given purpose
S-8
EX-4.3
jhm0j9ofk g2m
23 Jan 24
Registration of securities for employees
4:16pm
S-8
rfrol5jsnj
23 Jan 24
Registration of securities for employees
4:16pm
S-8
EX-5.1
mcbdy
23 Jan 24
Registration of securities for employees
4:16pm
S-8
dmt8elnb
23 Jan 24
Registration of securities for employees
4:16pm
6-K
EX-3.1
gc8tak71ougv0y5f75ut
18 Dec 23
Current report (foreign)
4:10pm
6-K
EX-99.1
fee0w6ygnnly2jn4p
16 Nov 23
Current report (foreign)
7:01am
6-K
EX-99.2
q7j463c4
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-99.2
mc2lr
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
EX-99.1
q6m7v9x7
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
6-K
EX-3.1
qfwb h7mgar3
17 May 22
Current report (foreign)
8:26am